Necrotizing Fasciitis Treatment Market

About this report

The global Necrotizing Fasciitis Treatment Market report explores the critical analysis of the necrotizing fasciitis treatment industry using key parameters. The report consists of investment strategies, the need for investments in the necrotizing fasciitis treatment industry, and the multiple benefits for investors. Importantly, this report sets out major changes in the global technical regulations for the necrotizing fasciitis treatment industry and how economic and non-economic barriers are helping the necrotizing fasciitis treatment market. 

Moreover, the report analyses the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter’s five forces analysis, PESTEL analysis, value chain analysis, etc.

Key Highlights of the report

How are the major segments performing in the Necrotizing Fasciitis Treatment Market?

• In 2021, type I necrotizing fasciitis treatment will be the leading segment because there are more cases of type I necrotizing fasciitis.
• In 2021, the penicillin G-based necrotizing fasciitis treatment drugs segment in the drug type will lead the market since they destroy bacteria or stop their growth; antibiotics are most frequently utilized.
• In 2021, the necrotizing fasciitis treatment drug sales via hospital pharmacies segment in the end-use industry will lead the market because there will be more hospital pharmacies over the forecasted era. 

Which region dominated the Necrotizing Fasciitis Treatment Market?

In 2021, North America was one of the major contributors to the global Necrotizing Fasciitis Treatment market due to the market for necrotizing fasciitis treatments having large participants and the growing significance of finding and treating rare diseases. The market for necrotizing fasciitis treatments is expected to rise more quickly due to the public’s greater awareness of bacterial infections. The United States has the greatest market in this region, followed by Canada, and North America has the largest market share.

What is the competitive environment of the Necrotizing Fasciitis Treatment Market?

Numerous domestic companies enjoy significant market shares in their regions in the global market for necrotizing fasciitis treatments. Consolidation of the market is partly attributable to high research and development costs and the length of the clinical trial procedure. The market for treating necrotizing fasciitis on a global scale is drawing many home producers. The major competitors in the global market for necrotizing fasciitis treatments concentrate on corporate growth and participate in mergers and partnerships.

Executive Summary

What contributes to Necrotizing Fasciitis’s increased prevalence?

Necrotizing Fasciitis, often known as flesh-eating illness, is a rare but serious bacterial infection that affects the tissue underneath the skin and nearby organs and muscles. Necrotizing fasciitis develops swiftly after a slight injury. When co-morbid conditions, including immunosuppression, chronic alcoholism, chronic renal failure, liver cirrhosis, and diabetes mellitus, are present, the prognosis for necrotizing fasciitis becomes poor. Necrotizing fasciitis must be diagnosed as soon as possible because any delay could result in more complicated surgery, a higher likelihood of amputation, and a higher mortality rate. 

The infection that causes necrotizing can cause systemic inflammatory response syndrome if left untreated. The market for necrotizing fasciitis therapy will be driven by an increase in the frequency of chronic disease, a greater emphasis on research and development of uncommon diseases, and new technology. Treatment options for necrotizing fasciitis include surgery to remove diseased tissues, antibiotics, and supportive care to manage fluid levels, blood pressure, and organ function.

Which are the key investments by the players in the Necrotizing Fasciitis Treatment Industry Market?

The market for Necrotizing Fasciitis Treatment is expected to be driven shortly by recent developments in drug development, an increase in the number of drugs in clinical trials, and a focus on biological and technological advancements. Substantial R&D efforts, as well as rising government backing, are being made to cure rare diseases. 

Some major players in the Necrotizing Fasciitis Treatment market are GlaxoSmithKline Plc., Pfizer Inc., Bristol-Myers Squibb Company, Merck & Co., Inc, Abbott, Teva Pharmaceutical Industries Ltd, Basilea Pharmaceutica Ltd., MELINTA THERAPEUTICS, Atox Bio, WOCKHARDT, and others.

What are the Major Driving Factors for the Necrotizing Fasciitis Treatment Market?

The market for necrotizing fasciitis therapy will be driven in the future by chronic disease prevalence, the growing emphasis on R&D of uncommon diseases, and the development of new technology. Additionally, major factors that support the growth of the global market include the rising incidence of cancer and diabetes, the steadily aging population, and the rising number of patients with various bacterial illnesses. The market for treating necrotizing fasciitis is expected to rise due to rising awareness, wound and trauma therapy innovations, and breakthroughs in detecting rare diseases. 

What are the Major Risks for the Necrotizing Fasciitis Treatment Market?

Non-steroidal anti-inflammatory drugs (NSAIDs) and steroids are used to suppress a fever, making it harder to diagnose the condition and, lacking defined treatment and diagnostic criteria, impeding the growth of the necrotizing fasciitis treatment market. Due to a lack of awareness about necrotizing fasciitis and the high cost of therapy, the expansion of the market for necrotizing fasciitis treatments is constrained.

Which is the key type in the Necrotizing Fasciitis Treatment Market?

Due to an increase in type I necrotizing fasciitis occurrences, type I necrotizing fasciitis treatment will be the dominant market in 2021. It mainly affects the torso and perineum and is caused by a polymicrobial infection that commonly contains group A streptococci (such as Streptococcus pyogenes) and a combination of aerobic and anaerobic bacteria (e.g., Bacteroides species). These organisms generally spread to subcutaneous tissue following an adjacent lesion or infection.

How is the Necrotizing Fasciitis Treatment Market performing in regions?

In 2021, the global Necrotizing Fasciitis Treatment market was dominated by North America due to the existence of major market participants in necrotizing fasciitis treatment and the growing importance placed on the identification and treatment of rare diseases. Growing public awareness of bacterial infections is expected to hasten the market’s expansion for necrotizing fasciitis treatment. The U.S. is the largest market in this region, followed by Canada, and North America accounts for the largest market share. The prevalence of cardiovascular disease has risen in the United States over the past several years. This results from the key risk factors for cardiovascular illnesses, such as obesity and diabetes, which are chronic diseases with an increased prevalence.

Besides, the Asia-Pacific region is expected to grow significantly over the forecast period. The primary factor driving market expansion is the rising prevalence of chronic diseases like diabetes, cancer, and bacterial infections in emerging nations. Due to the growing elderly population, China and India are the two regions with the fastest growing economies. Diabetes is one of the main chronic disorders that affect many patients, which impacts the market’s expansion. The market in this area is driven by growing public awareness of infections and the availability of new treatment options. The market is also driven by rising healthcare costs and the general expansion of the diagnostic and treatment sectors of the healthcare industry.

What is the regulatory landscape for the Necrotizing Fasciitis Treatment Market?

There are numerous medication candidates in various phases of clinical trials in the United States. 500 to 1,000 new cases of necrotizing fasciitis are reported in the United States every year, according to the Centers for Disease Control and Prevention (CDC). The market for treating necrotizing fasciitis is anticipated to expand quickly due to government financing for uncommon diseases and clinical trials, the high prevalence of chronic diseases, and improving healthcare infrastructure in emerging nations. Additionally, the demand for research and development of biologics and biosimilars for necrotizing fasciitis is driven by increased healthcare spending.

What is the Market Size of the Necrotizing Fasciitis Treatment regarding value?

The global Necrotizing Fasciitis Treatment Market is anticipated to grow at a substantial CAGR of 4.00% in the upcoming years. The global Necrotizing Fasciitis Treatment industry was estimated to be worth USD 2.2 billion in 2021 and was expected to be worth USD 2.8 billion by 2028.

What are the major players planning for the future of the Necrotizing Fasciitis Treatment Market?

The global market for necrotizing fasciitis therapy is predicted to benefit from an increase in R&D activity and the development of treatment facilities. The market for necrotizing fasciitis treatment is also driven by increased awareness, wound and trauma treatment advancements, and diagnostic innovations for rare diseases.

Segmentation of Global Necrotizing Fasciitis Treatment Market-

Global Necrotizing Fasciitis Treatment Market – By Type

• Type I Necrotizing Fasciitis Treatment
• Type II Necrotizing Fasciitis Treatment
• Type III Necrotizing Fasciitis Treatment
• Type IV Necrotizing Fasciitis Treatment

Global Necrotizing Fasciitis Treatment Market – By Drug Type

• Penicillin G-based Necrotizing Fasciitis Treatment Drugs
• Carbapenems-based Necrotizing Fasciitis Treatment Drugs
• Metronidazole-based Necrotizing Fasciitis Treatment Drugs
• Aminoglycoside-based Necrotizing Fasciitis Treatment Drugs
• Clindamycin-based Necrotizing Fasciitis Treatment Drugs
• Fluoroconazoles-based Necrotizing Fasciitis Treatment Drugs
• Other Necrotizing Fasciitis Treatment Drugs

Global Necrotizing Fasciitis Treatment Market – By Distribution Channel

• Necrotizing Fasciitis Treatment Drug Sales via Hospital Pharmacies
• Necrotizing Fasciitis Treatment Drug Sales via Retail Pharmacies
• Necrotizing Fasciitis Treatment Drug Sales via Drug Stores
• Necrotizing Fasciitis Treatment Drug Sales via E-Commerce Platforms

Global Necrotizing Fasciitis Treatment Market – By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Necrotizing Fasciitis Treatment Market
2.2. Global Necrotizing Fasciitis Treatment Market, By Type
2.3. Global Necrotizing Fasciitis Treatment Market, By Drug Type
2.4. Global Necrotizing Fasciitis Treatment Market, By Distribution Channel
2.5. Global Necrotizing Fasciitis Treatment Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Necrotizing Fasciitis Treatment Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Market Drivers
3.2.3. Market Restraints
3.2.4. Market Opportunities
3.2.5. Major Industry Challenges
3.3. Attractive Investment Proposition,2021
3.3.1. Type
3.3.2. Drug Type
3.3.3. Distribution Channel
3.3.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Value Chain Analysis
4.4. Technology Analysis
4.5. Marketing Strategy Analysis
4.5.1. Direct Marketing
4.5.2. Indirect Marketing
4.5.3. Marketing Channel Development Trend
5. Market Positioning of Key Players, 2021
5.1. Company market share of key players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. COVID 19 Impact Analysis
6.1. Global Necrotizing Fasciitis Treatment Market Pre Vs Post COVID 19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global Necrotizing Fasciitis Treatment Market
7.1. Global Necrotizing Fasciitis Treatment Market, by Type, 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global Necrotizing Fasciitis Treatment Market, By Type, 2021 vs 2028 (in%)
7.1.3. Global Necrotizing Fasciitis Treatment Market, By Type I Necrotizing Fasciitis Treatment, 2016-2028 (US$ Bn)
7.1.4. Global Necrotizing Fasciitis Treatment Market, By Type II Necrotizing Fasciitis Treatment, 2016-2028 (US$ Bn)
7.1.5. Global Necrotizing Fasciitis Treatment Market, By Type III Necrotizing Fasciitis Treatment, 2016-2028 (US$ Bn)
7.1.6. Global Necrotizing Fasciitis Treatment Market, By Type IV Necrotizing Fasciitis Treatment, 2016-2028 (US$ Bn)
7.2. Global Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global Necrotizing Fasciitis Treatment Market, By Drug Type, 2021 vs 2028 (in%)
7.2.3. Global Necrotizing Fasciitis Treatment Market, By Penicillin G-based Necrotizing Fasciitis Treatment Drugs, 2016-2028 (US$ Bn)
7.2.4. Global Necrotizing Fasciitis Treatment Market, By Carbapenemes-based Necrotizing Fasciitis Treatment Drugs, 2016-2028 (US$ Bn)
7.2.5. Global Necrotizing Fasciitis Treatment Market, By Metronidazole-based Necrotizing Fasciitis Treatment Drugs, 2016-2028 (US$ Bn)
7.2.6. Global Necrotizing Fasciitis Treatment Market, By Aminoglycoside-based Necrotizing Fasciitis Treatment Drugs, 2016-2028 (US$ Bn)
7.2.7. Global Necrotizing Fasciitis Treatment Market, By Clindamycin-based Necrotizing Fasciitis Treatment Drugs, 2016-2028 (US$ Bn)
7.2.8. Global Necrotizing Fasciitis Treatment Market, By Fluoroconazoles-based Necrotizing Fasciitis Treatment Drugs, 2016-2028 (US$ Bn)
7.2.9. Global Necrotizing Fasciitis Treatment Market, By Other Necrotizing Fasciitis Treatment Drugs, 2016-2028 (US$ Bn)
7.3. Global Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Global Necrotizing Fasciitis Treatment Market, By Distribution Channel, 2021 vs 2028 (in%)
7.3.3. Global Necrotizing Fasciitis Treatment Market, By Necrotizing Fasciitis Treatment Drug Sales via Hospital Pharmacies, 2016-2028 (US$ Bn)
7.3.4. Global Necrotizing Fasciitis Treatment Market, By Necrotizing Fasciitis Treatment Drug Sales via Retail Pharmacies, 2016-2028 (US$ Bn)
7.3.5. Global Necrotizing Fasciitis Treatment Market, By Necrotizing Fasciitis Treatment Drug Sales via Drug Stores, 2016-2028 (US$ Bn)
7.3.6. Global Necrotizing Fasciitis Treatment Market, By Necrotizing Fasciitis Treatment Drug Sales via E-Commerce Platforms, 2016-2028 (US$ Bn)

8. North America Necrotizing Fasciitis Treatment Market Analysis
8.1. North America Necrotizing Fasciitis Treatment Market, by Type, 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Necrotizing Fasciitis Treatment Market, by Country, 2016-2028 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.1.2. U.S. Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
8.4.1.3. U.S. Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
8.4.1.4. U.S. Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.2.2. Canada Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
8.4.2.3. Canada Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
8.4.2.4. Canada Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)

9. Europe Necrotizing Fasciitis Treatment Market Analysis
9.1. Europe Necrotizing Fasciitis Treatment Market, by Type, 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Necrotizing Fasciitis Treatment Market, by Country, 2016-2028 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.1.2. Germany Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
9.4.1.3. Germany Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
9.4.1.4. Germany Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
9.4.2. France
9.4.2.1. France Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.2.2. France Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
9.4.2.3. France Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
9.4.2.4. France Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
9.4.3. UK
9.4.3.1. UK Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.3.2. UK Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
9.4.3.3. UK Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
9.4.3.4. UK Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
9.4.4. Italy
9.4.4.1. Italy Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.4.2. Italy Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
9.4.4.3. Italy Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
9.4.4.4. Italy Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.5.2. Spain Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
9.4.5.3. Spain Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
9.4.5.4. Spain Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.6.2. Rest of Europe Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
9.4.6.3. Rest of Europe Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
9.4.6.4. Rest of Europe Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)

10. Asia Pacific Necrotizing Fasciitis Treatment Market Analysis
10.1. Asia Pacific Necrotizing Fasciitis Treatment Market, by Type, 2016-2028(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Necrotizing Fasciitis Treatment Market, by Country, 2016-2028 (US$ Bn)
10.4.1. China
10.4.1.1. China Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.1.2. China Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
10.4.1.3. China Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
10.4.1.4. China Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
10.4.2. Japan
10.4.2.1. Japan Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.2.2. Japan Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
10.4.2.3. Japan Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
10.4.2.4. Japan Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
10.4.3. India
10.4.3.1. India Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.3.2. India Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
10.4.3.3. India Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
10.4.3.4. India Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
10.4.4. South Korea
10.4.4.1. South Korea Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.4.2. South Korea Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
10.4.4.3. South Korea Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
10.4.4.4. South Korea Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
10.4.5. South-East Asia
10.4.5.1. South-East Asia Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.5.2. South-East Asia Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
10.4.5.3. South-East Asia Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
10.4.5.4. South-East Asia Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.6.2. Rest of Asia Pacific Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
10.4.6.3. Rest of Asia Pacific Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
10.4.6.4. Rest of Asia Pacific Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)

11. Latin America Necrotizing Fasciitis Treatment Market Analysis
11.1. Latin America Necrotizing Fasciitis Treatment Market, by Type, 2016-2028(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Necrotizing Fasciitis Treatment Market, by Country, 2016-2028 (US$ Bn)
11.4.1. Brazil
11.4.1.1. Brazil Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.1.2. Brazil Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
11.4.1.3. Brazil Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
11.4.1.4. Brazil Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
11.4.2. Mexico
11.4.2.1. Mexico Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.2.2. Mexico Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
11.4.2.3. Mexico Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
11.4.2.4. Mexico Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.3.2. Rest of Latin America Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
11.4.3.3. Rest of Latin America Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
11.4.3.4. Rest of Latin America Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)

12. Middle East and Africa Necrotizing Fasciitis Treatment Market Analysis
12.1. Middle East and Africa Necrotizing Fasciitis Treatment Market, by Type, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Necrotizing Fasciitis Treatment Market, by Country, 2016-2028 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries il Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.1.2. GCC Countries Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
12.4.1.3. GCC Countries Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
12.4.1.4. GCC Countries Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.2.2. South Africa Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
12.4.2.3. South Africa Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
12.4.2.4. South Africa Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa Necrotizing Fasciitis Treatment Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa Necrotizing Fasciitis Treatment, By Type, 2016-2028 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa Necrotizing Fasciitis Treatment, By Drug Type, 2016-2028 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa Necrotizing Fasciitis Treatment, By Distribution Channel, 2016-2028 (US$ Bn)

13. Company Profiles
13.1. Pfizer Inc.
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. GlaxoSmithKline Plc.
13.3. Bristol-Myers Squibb Company
13.4. Merck & Co., Inc
13.5. Abbott
13.6. Teva Pharmaceutical Industries Ltd
13.7. Basilea Pharmaceutica Ltd.
13.8. MELINTA THERAPEUTICS
13.9. Atox Bio
13.10. WOCKHARDT
13.11. Others

List of Figures
FIG. 1 Global Necrotizing Fasciitis Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Necrotizing Fasciitis Treatment Market Segmentation
FIG. 4 Global Necrotizing Fasciitis Treatment Market, by Type, 2021 (US$ Bn)
FIG. 5 Global Necrotizing Fasciitis Treatment Market, by Drug Type, 2021 (US$ Bn)
FIG. 6 Global Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2021 (US$ Bn)
FIG. 7 Global Necrotizing Fasciitis Treatment Market, by Geography, 2021 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Type, 2021
FIG. 9 Attractive Investment Proposition, by Drug Type, 2021
FIG. 10 Attractive Investment Proposition, by Distribution Channel, 2021
FIG. 11 Attractive Investment Proposition, by Geography, 2021
FIG. 12 Global Market Share Analysis of Key Necrotizing Fasciitis Treatment Market Manufacturers, 2021
FIG. 13 Global Market Positioning of Key Necrotizing Fasciitis Treatment Market Manufacturers, 2021
FIG. 14 Global Necrotizing Fasciitis Treatment Market Value Contribution, By Type, 2021 & 2028 (Value %)
FIG. 15 Global Necrotizing Fasciitis Treatment Market, by Type I Necrotizing Fasciitis Treatment, Value, 2016-2028 (US$ Bn)
FIG. 16 Global Necrotizing Fasciitis Treatment Market, by Type II Necrotizing Fasciitis Treatment, Value, 2016-2028 (US$ Bn)
FIG. 17 Global Necrotizing Fasciitis Treatment Market, by Type III Necrotizing Fasciitis Treatment, Value, 2016-2028 (US$ Bn)
FIG. 18 Global Necrotizing Fasciitis Treatment Market, by Type IV Necrotizing Fasciitis Treatment, Value, 2016-2028 (US$ Bn)
FIG. 19 Global Necrotizing Fasciitis Treatment Market Value Contribution, By Drug Type, 2021 & 2028 (Value %)
FIG. 20 Global Necrotizing Fasciitis Treatment Market, by Penicillin G-based Necrotizing Fasciitis Treatment Drugs, Value, 2016-2028 (US$ Bn)
FIG. 21 Global Necrotizing Fasciitis Treatment Market, by Carbapenemes-based Necrotizing Fasciitis Treatment Drugs, Value, 2016-2028 (US$ Bn)
FIG. 22 Global Necrotizing Fasciitis Treatment Market, by Metronidazole-based Necrotizing Fasciitis Treatment Drugs, Value, 2016-2028 (US$ Bn)
FIG. 23 Global Necrotizing Fasciitis Treatment Market, by Aminoglycoside-based Necrotizing Fasciitis Treatment Drugs, Value, 2016-2028 (US$ Bn)
FIG. 24 Global Necrotizing Fasciitis Treatment Market, by Clindamycin-based Necrotizing Fasciitis Treatment Drugs, Value, 2016-2028 (US$ Bn)
FIG. 25 Global Necrotizing Fasciitis Treatment Market, by Fluoroconazoles-based Necrotizing Fasciitis Treatment Drugs, Value, 2016-2028 (US$ Bn)
FIG. 26 Global Necrotizing Fasciitis Treatment Market, by Other Necrotizing Fasciitis Treatment Drugs, Value, 2016-2028 (US$ Bn)
FIG. 27 Global Necrotizing Fasciitis Treatment Market Value Contribution, By Distribution Channel, 2021 & 2028 (Value %)
FIG. 28 Global Necrotizing Fasciitis Treatment Market, by Necrotizing Fasciitis Treatment Drug Sales via Hospital Pharmacies, Value, 2016-2028 (US$ Bn)
FIG. 29 Global Necrotizing Fasciitis Treatment Market, by Necrotizing Fasciitis Treatment Drug Sales via Retail Pharmacies, Value, 2016-2028 (US$ Bn)
FIG. 30 Global Necrotizing Fasciitis Treatment Market, by Necrotizing Fasciitis Treatment Drug Sales via Drug Stores, Value, 2016-2028 (US$ Bn)
FIG. 31 Global Necrotizing Fasciitis Treatment Market, by Necrotizing Fasciitis Treatment Drug Sales via E-Commerce Platforms, Value, 2016-2028 (US$ Bn)
FIG. 32 U.S. Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 33 Canada Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 34 Germany Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 35 France Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 36 U.K. Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 37 Italy Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 38 Spain Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 39 Rest of Europe Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 40 China Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 41 Japan Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 42 India Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 43 South Korea Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 44 Southeast Asia Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 45 Rest of Asia Pacific Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 46 Latin America Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 47 Brazil Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 48 Mexico Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 49 Rest of Latin America Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 50 Middle East & Africa Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 51 GCC Countries Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 52 South Africa Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)
FIG. 53 Rest of Middle East and Africa Necrotizing Fasciitis Treatment Market, 2016-2028 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Necrotizing Fasciitis Treatment Market
TABLE 2 Global Necrotizing Fasciitis Treatment Market, by Competitive Benchmarking, 2021
TABLE 3 Global Necrotizing Fasciitis Treatment Market, by Geographical Presence Analysis, 2021
TABLE 4 Global Necrotizing Fasciitis Treatment Market, by Key Strategies Analysis, 2021
TABLE 5 Global Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 6 Global Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 7 Global Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 8 Global Necrotizing Fasciitis Treatment Market, by Geography, 2016-2028 (US$ Bn)
TABLE 9 North America Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 10 North America Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 11 North America Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 12 North America Necrotizing Fasciitis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 13 US Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 14 US Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 15 US Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 16 Canada Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 17 Canada Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 18 Canada Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 19 Europe Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 20 Europe Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 21 Europe Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 22 Europe Necrotizing Fasciitis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 23 Germany Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 24 Germany Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 25 Germany Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 26 France Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 27 France Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 28 France Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 29 UK Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 30 UK Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 31 UK Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 32 Italy Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 33 Italy Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 34 Italy Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 35 Spain Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 36 Spain Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 37 Spain Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 38 Rest of Europe Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 39 Rest of Europe Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 40 Rest of Europe Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 41 Asia Pacific Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 42 Asia Pacific Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 43 Asia Pacific Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 44 Asia Pacific Necrotizing Fasciitis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 45 China Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 46 China Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 47 China Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 48 Japan Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 49 Japan Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 50 Japan Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 51 India Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 52 India Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 53 India Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 54 South Korea Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 55 South Korea Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 56 South Korea Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 57 South East Asia Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 58 South East Asia Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 59 South East Asia Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 60 Rest of Asia Pacific Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 61 Rest of Asia Pacific Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 62 Rest of Asia Pacific Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 63 Latin America Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 64 Latin America Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 65 Latin America Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 66 Latin America Necrotizing Fasciitis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 67 Brazil Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 68 Brazil Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 69 Brazil Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 70 Mexico Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 71 Mexico Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 72 Mexico Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 73 Rest of Latin America Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 74 Rest of Latin America Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 75 Rest of Latin America Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 76 Middle East and Africa Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 77 Middle East and Africa Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 78 Middle East and Africa Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 79 Middle East and Africa Necrotizing Fasciitis Treatment Market, by Country, 2016-2028 (US$ Bn)
TABLE 80 GCC Countries Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 81 GCC Countries Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 82 GCC Countries Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 83 South Africa Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 84 South Africa Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 85 South Africa Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 86 Rest of Middle East and Africa Necrotizing Fasciitis Treatment Market, by Type, 2016-2028 (US$ Bn)
TABLE 87 Rest of Middle East and Africa Necrotizing Fasciitis Treatment Market, by Drug Type, 2016-2028 (US$ Bn)
TABLE 88 Rest of Middle East and Africa Necrotizing Fasciitis Treatment Market, by Distribution Channel, 2016-2028 (US$ Bn)